Cellebrite DI Ltd

Cellebrite DI Ltd (CLBT) Stock Analysis

$11.500

+0.131 (+1.14%)At close

Loading chart…
High
11.565
Open
11.370
VWAP
11.48
Volume
885.12K
Mkt Cap
2.43B
Low
11.370
Amount
10.16M
EV/EBITDA, TTM
47.46

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

AI analysis of Cellebrite DI Ltd (CLBT)

Hold

Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.

Valuation Metrics

The current forward P/E ratio for Cellebrite DI Ltd (CLBT) is 35.71, compared to its 5-year average forward P/E of 41.14.

Forward P/E

Fair
5Y Average P/E
41.14
Current P/E
35.71
Overvalued
57.13
Undervalued
25.14

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
30.06
Current EV/EBITDA
47.46
Overvalued
42.30
Undervalued
17.82

Forward P/S

Fair
5Y Average P/S
5.64
Current P/S
4.37
Overvalued
7.90
Undervalued
3.38

Alphio AI Price Scenarios for CLBT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLBT

$24.00

Scenario price

B

Base

Base · 50%CLBT

$20.91

Scenario price

B

Bear

Bear · 25%CLBT

$20.21

Scenario price

Whales holding CLBT

P

Phoenix Investments & Finances Ltd

+ HoldingCLBT

+9.81%

3M Return

P

Portolan Capital Management, LLC

+ HoldingCLBT

+2.36%

3M Return

W

Weiss Asset Management, LLC

+ HoldingCLBT

-0.98%

3M Return

V

Voss Capital, LP

+ HoldingCLBT

-1.59%

3M Return

C

Clal Financial Management Ltd

+ HoldingCLBT

-4.23%

3M Return

Events Timeline

2026-09-14 (ET)

08:30:00

Cellebrite Board Approves Corporate Reorganization Plan

2026-09-02 (ET)

09:00:00

Cellebrite Guardian Achieves IRAP Certification

2026-08-13 (ET)

16:30:00

Major Averages Rise as Oil Prices Fall

12:30:00

Cellebrite Shares Drop 31.8% to $10.40

12:00:00

Major Averages Rise as Oil Prices Fall

News

CLBT FAQ — answered by Alphio AI

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.

Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading